Cindy Jacobs
2019
In 2019, Cindy Jacobs earned a total compensation of $580.9K as Executive Vice President and Chief Medical Officer at OncoGenex Pharmaceuticals, a 18% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $123,970 |
---|---|
Option Awards | $43,657 |
Salary | $413,230 |
Total | $580,857 |
Jacobs received $413.2K in salary, accounting for 71% of the total pay in 2019.
Jacobs also received $124K in non-equity incentive plan and $43.7K in option awards.
Rankings
In 2019, Cindy Jacobs' compensation ranked 11,304th out of 13,971 executives tracked by ExecPay. In other words, Jacobs earned more than 19.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 11,304 | 19th |
Manufacturing | 4,579 | 20th |
Chemicals And Allied Products | 1,800 | 18th |
Drugs | 1,548 | 18th |
In Vitro and In Vivo Diagnostic Substances | 52 | 33rd |
Jacobs' colleagues
We found three more compensation records of executives who worked with Cindy Jacobs at OncoGenex Pharmaceuticals in 2019.
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019